Revisão Acesso aberto Revisado por pares

New Small-Molecule Synthetic Antimycobacterials

2005; American Society for Microbiology; Volume: 49; Issue: 6 Linguagem: Inglês

10.1128/aac.49.6.2153-2163.2005

ISSN

1098-6596

Autores

Lluís Ballell, Robert A. Field, Ken Duncan, Robert J. Young,

Tópico(s)

Cancer therapeutics and mechanisms

Resumo

Drugs for treating tuberculosis (TB) have been available for over half a century, and yet the incidence of disease worldwide continues to rise year by year. In 2002, the last year for which statistics are available, it is estimated that 24,000 people developed active disease and close to 5,000

Referência(s)